Evidence map›Paper›PMID 37711887›Full record

ArticleFrontiers in endocrinology2023

Pharmaceutical efficacy of novel human-origin

Meng Yang, Jing-Hua Wang, Joo-Hyun Shin, Dokyung Lee, Sang-Nam Lee, Jae-Gu Seo, Ji-Hee Shin, Young-Do Nam, Hojun Kim, Xiaomin Sun

Abstract read
In one paragraph

Article in Frontiers in endocrinology, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 22 papers.

0numbers the graph read from it
0cells of the map it votes in
22citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

22 citing papers in PubMed.

  1. Trial
  2. Article
  3. Review
  4. Review
  5. Article
  6. Review
  7. Review
  8. Review
  9. Review
  10. Article
  11. Gut microbes · 2025
    Article
  12. Review
  13. Review
  14. Article
  15. Review
  16. Article
  17. Review
  18. Review
  19. Review
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors.

Meng YangDepartment of Nephrology, Integrated Hospital of Traditional Chinese Medicine, Southern Medical University, Guangzhou, Guangdong, China.
Jing-Hua WangInstitute of Bioscience & Integrative Medicine, Daejeon University, Daejeon, Republic of Korea.
Joo-Hyun ShinR&D Center, Enterobiome Inc., Goyang-si, Republic of Korea.
Dokyung LeeR&D Center, Enterobiome Inc., Goyang-si, Republic of Korea.
Sang-Nam LeeR&D Center, Enterobiome Inc., Goyang-si, Republic of Korea.
Jae-Gu SeoR&D Center, Enterobiome Inc., Goyang-si, Republic of Korea.
Ji-Hee ShinResearch Group of Healthcare, Korea Food Research Institute, Wanju-gun, Republic of Korea.
Young-Do NamResearch Group of Healthcare, Korea Food Research Institute, Wanju-gun, Republic of Korea.
Hojun KimDepartment of Rehabilitation Medicine of Korean Medicine, Dongguk University, Goyang-si, Republic of Korea.
Xiaomin SunDepartment of Nephrology, Integrated Hospital of Traditional Chinese Medicine, Southern Medical University, Guangzhou, Guangdong, China.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Introduction: Obesity and related metabolic issues are a growing global health concern. Recently, the discovery of new probiotics with anti-obesity properties has gained interest. Methods: In this study, four Results: The Discussion: In summary, the novel isolated

Indexed as

Faecalibacterium prausnitziiMetabolic DiseasesAnimalsDiet, High-FatHumansMiceObesityPharmaceutical PreparationsPharmaceutical Preparationsanti-obesityappetiteFaecalibacterium prausnitziigut–brain axisgut microbiotametabolic disordersprobiotics

Identifiers

PMID37711887
PMCPMC10497875

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.